Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 315 of 1,261
  1. US 11118160

    Probiotic composition for enhancing an insects resistance to a pesticide

    The Regents of the University of California · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  2. US 11118169

    Compositions for increasing polypeptide stability and activity, and related methods

    Solis BioDyne OÜ · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  3. US 11118167

    Enzyme-mediated depletion of adenosine and/or methylthioadenosine

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  4. US 11117975

    Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  5. US 11117973

    Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

    Inhibrx, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  6. US 11118178

    Reduced size self-delivering RNAI compounds

    Phio Pharmaceuticals Corp. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  7. US 11116733

    Topical dapsone and dapsone/adaplene compositions and methods for use thereof

    ALMIRALL, LLC · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  8. US 11117970

    Human antibodies to PD-L1

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  9. US 11117968

    Activatable anti-CTLA-4 antibodies and uses thereof

    CytomX Therapeutics, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  10. US 11117955

    Anti-Zika virus antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  11. US 11117972

    Multivalent and multispecific OX40-binding fusion proteins

    Inhibrx, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  12. US 11117904

    Compositions and methods for the delivery of therapeutics

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  13. US 11117900

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  14. US 11117899

    [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

    Medshine Discovery Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  15. US 11117888

    Irreversible inhibitors of pyruvate kinase M2 and the use thereof

    China Medical University · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  16. US 11117884

    Potent gamma-secretase modulators

    The Regents of the University of California · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  17. US 11117889

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  18. US 11117867

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  19. US 11116843

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  20. US 11116839

    Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  21. US 11116838

    Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  22. US 11116830

    Bacterial polysaccharide-conjugated carrier proteins and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  23. US 11116717

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  24. US 11111317

    Cordyceps militaris medium polysaccharide, method for separating and purifying same, and use thereof

    SOUTH CHINA NORMAL UNIVERSITY · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.